• Home
  • Publications
  • The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd

The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd

ACS Med. Chem. Lett. 2022, 13 (7), 992-996

DOI: 10.1021/acsmedchemlett.2c00211

Kondratov I.; Moroz Y.; Grygorenko O.; Tolmachev A.

Ukrainian companies occupy an important niche in the global drug discovery process; however, before the Russian invasion, the role of Ukraine was not obvious. The biggest Ukrainian fine chemical supplier, Enamine Ltd, had to stop operation for more than a month, which significantly affected various early-stage drug discovery projects. The role of Enamine in drug discovery and the company’s past and future in the context of the Russian invasion are described in this Viewpoint.

The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd

FOLLOW US